Pluri Inc. (PLUR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2026, filed Sep 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PLUR SEC filings page.
Pluri Inc. (PLUR) reported $1.0M in revenue for fiscal year 2026, down 24.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Pluri remains a development-stage business: modest revenue, rising research spending, recurring cash consumption, and a balance sheet increasingly funded by obligations.
The key shift is not simply larger losses: from FY2025 to FY2026, revenue fell while R&D increased and operating cash outflow widened, indicating the cost base did not flex with activity. At the same time, liabilities rose as total assets contracted, so financing pressure intensified even though annual operating cash use stayed near$20M .
Revenue reached only
Liquidity tightened sharply: the current ratio fell from 0.7x to 0.3x. With equity at
Financial Health Signals
Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Pluri Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Pluri Inc. held $3.5M in cash, cash equivalents and investments at the end of fiscal year 2026, and its operations used $19.6M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Pluri Inc. scores 9/100 among other emerging companies.
Pluri Inc. had 12M shares outstanding at the end of fiscal year 2026. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Pluri Inc. scores 20/100 among other emerging companies.
Pluri Inc. spent $15.1M on research and development in fiscal year 2026, which was 58.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Pluri Inc. scores 81/100 among other emerging companies.
Pluri Inc. reported revenue of $1.0M in fiscal year 2026, against $1.3M in fiscal year 2025. Revenue Progress ranks emerging companies on the three-year path of that line, and Pluri Inc. scores 83/100 among other emerging companies.
Pluri Inc.'s operations used $19.6M of cash in fiscal year 2026, against $18.2M used in fiscal year 2025. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Pluri Inc. scores 40/100 among other emerging companies.
Pluri Inc.'s cash, cash equivalents and investments came to $3.5M at the end of fiscal year 2026, against $47.9M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Pluri Inc. scores 13/100 among other emerging companies.
Pluri Inc. scores -30.55, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($12.0M) relative to total liabilities ($47.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Pluri Inc. passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
Pluri Inc. reported a net loss of $23.8M while operations used $19.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Pluri Inc. reported an operating loss of $24.9M against $932K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Pluri Inc. generated $335K in revenue in Q4 2026. This represents a decrease of 15.8% from the same quarter a year earlier. Against the prior quarter it is up 100.6%.
Pluri Inc.'s EBITDA was -$5.4M in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 16.7% from the same quarter a year earlier. Against the prior quarter it is up 15.4%.
Pluri Inc. reported -$5.9M in net income in Q4 2026. This represents an increase of 22.6% from the same quarter a year earlier. Against the prior quarter it is down 6.0%.
Pluri Inc. earned -$0.54 per diluted share (EPS) in Q4 2026. This represents an increase of 46.0% from the same quarter a year earlier. Against the prior quarter it is up 1.8%.
Cash & Balance Sheet
Pluri Inc. recorded an outflow of $4.5M in free cash flow in Q4 2026, representing a cash shortfall after capex. This represents an increase of 24.7% from the same quarter a year earlier. Against the prior quarter it is up 1.9%.
Pluri Inc. held $3.5M in cash as of Q4 2026; long-term debt is not reported for that period.
Not reported for Q4 2026.
Margins & Returns
Pluri Inc.'s gross margin was 58.5% in Q4 2026, indicating the percentage of revenue retained after direct costs. This is up 6.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 25.0 percentage points.
Not shown for Q4 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q4 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q4 2026.
Capital Allocation
Pluri Inc. invested $3.4M in research and development in Q4 2026. This represents a decrease of 15.5% from the same quarter a year earlier. Against the prior quarter it is down 14.9%.
Pluri Inc. invested $26K in capex in Q4 2026, funding long-term assets and infrastructure. This represents a decrease of 96.4% from the same quarter a year earlier. Against the prior quarter it is down 40.9%.
Not reported for Q4 2026.
PLUR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $335K-15.8% | $167K-60.9% | $198K+7.0% | $316K-3.1% | $398K+314.6% | $427K+501.4% | $185K+76.2% | $326K+503.7% |
| Cost of Revenue | $139K-27.2% | $111K-61.9% | $112K+51.4% | $201K+59.5% | $191K | $291K | $74K | $126K |
| Gross Profit | $196K-5.3% | $56K-58.8% | $86K-22.5% | $115K-42.5% | $207K+125.0% | $136K+91.5% | $111K+5.7% | $200K+270.4% |
| R&D Expenses | $3.4M-15.5% | $4.0M+30.2% | $3.8M+30.8% | $3.9M+36.1% | $4.0M+17.6% | $3.0M-1.6% | $2.9M-1.3% | $2.9M-3.5% |
| SG&A Expenses | $2.4M-16.4% | $2.6M+5.5% | $2.8M+29.1% | $2.5M+1.0% | $2.8M+3.8% | $2.5M-0.7% | $2.1M-9.0% | $2.5M+2.9% |
| Operating Income | -$5.5M+16.2% | -$6.5M-21.0% | -$6.5M-31.2% | -$6.3M-22.2% | -$6.6M-9.7% | -$5.4M+2.4% | -$5.0M+4.9% | -$5.2M+3.3% |
| EBITDA | -$5.4M+16.7% | -$6.4M-20.3% | -$6.4M-30.4% | -$6.2M-21.2% | -$6.5M-9.0% | -$5.3M+2.6% | -$4.9M+5.0% | -$5.1M+3.3% |
| Interest Expense | $235K+0.9% | $237K+11.8% | $231K+9.5% | $229K+5.5% | $233K+6.9% | $212K-2.8% | $211K-2.3% | $217K+1.4% |
| Income Tax | -$1K | -$8K | -$8K | -$8K | N/A | N/A | N/A | N/A |
| Net Income | -$5.9M+22.6% | -$5.5M+9.7% | -$6.5M-121.3% | -$5.8M+0.5% | -$7.6M-120.8% | -$6.1M-16.1% | -$3.0M+39.7% | -$5.9M-18.6% |
| EPS (Basic) | -$0.54+46.0% | -$0.55+41.5% | -$0.71-34.0% | -$0.65+39.8% | -$1.00+6.5% | -$0.94+6.9% | -$0.53+44.8% | -$1.08-12.5% |
| EPS (Diluted) | -$0.54+46.0% | -$0.55 | -$0.71 | -$0.65 | -$1.00+6.5% | -$0.94+6.9% | -$0.53 | -$1.08-12.5% |
| Diluted Shares (Avg) | N/A | 10M | 9M | 9M | N/A | 7M+25.7% | 6M | 5M+5.7% |
PLUR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.9M-35.7% | $26.1M-30.3% | $30.6M-0.9% | $33.7M-5.0% | $38.7M-2.1% | $37.4M+2.8% | $30.9M-25.8% | $35.4M-20.4% |
| Current Assets | $8.7M-60.5% | $10.5M-61.9% | $13.8M-38.3% | $16.9M-37.4% | $22.1M-29.0% | $27.5M+0.3% | $22.4M-30.6% | $27.0M-23.3% |
| Cash & Equivalents | $3.5M-40.1% | $3.4M-59.8% | $4.7M-35.1% | $4.3M+33.2% | $5.9M-13.1% | $8.5M+20.0% | $7.2M+32.2% | $3.2M-39.1% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $3.1M0.0% | $3.1M | $3.1M | $3.1M | $3.1M | N/A | N/A | N/A |
| Total Liabilities | $47.9M+5.2% | $44.7M+6.6% | $45.2M+16.2% | $45.0M+10.6% | $45.5M+15.5% | $41.9M+14.0% | $38.9M+4.6% | $40.7M+14.3% |
| Current Liabilities | $32.7M+1.2% | $32.0M+461.0% | $32.3M+628.5% | $32.2M+601.7% | $32.3M+625.8% | $5.7M+26.0% | $4.4M-2.0% | $4.6M+6.0% |
| Non-Current Liabilities | $9.6M+32.9% | $7.0M-77.4% | $7.5M-74.6% | $7.2M-76.8% | $7.2M-75.7% | $31.2M+4.0% | $29.3M-3.5% | $30.9M+6.0% |
| Total Equity | -$23.0M-236.7% | -$18.6M-315.8% | -$14.6M-82.0% | -$11.4M-115.0% | -$6.8M-7227.1% | -$4.5M-1156.7% | -$8.0M-282.5% | -$5.3M-159.4% |
| Retained Earnings | -$466.9M-5.4% | -$461.0M-5.9% | -$455.4M-6.1% | -$448.9M-5.3% | -$443.1M-5.4% | -$435.5M-5.0% | -$429.3M-4.9% | -$426.4M-5.4% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Long-Term Debt.
PLUR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$4.4M+14.8% | -$4.5M-4.9% | -$5.2M-12.5% | -$5.4M-33.6% | -$5.2M-20.9% | -$4.3M-2.4% | -$4.6M-26.8% | -$4.1M+30.6% |
| Depreciation & Amortization | $124K+11.7% | $128K+77.8% | $129K+89.7% | $130K+100.0% | $111K+82.0% | $72K+18.0% | $68K+6.3% | $65K-3.0% |
| Stock-Based Compensation | N/A | $395K-14.7% | N/A | $1.4M+141.9% | N/A | $463K+976.7% | N/A | $558K-33.3% |
| Capital Expenditures | $26K-96.4% | $44K-92.4% | $447K+299.1% | $116K-44.2% | $721K+7110.0% | $577K+548.3% | $112K-7.4% | $208K+101.9% |
| Free Cash Flow | -$4.5M+24.7% | -$4.6M+6.6% | -$5.7M-19.2% | -$5.5M-29.8% | -$5.9M-37.3% | -$4.9M-13.7% | -$4.7M-25.7% | -$4.3M+28.3% |
| Investing Cash Flow | $1.6M-46.9% | $1.8M+142.2% | $2.7M-69.3% | $3.9M+558.1% | $3.0M+163.0% | -$4.2M-174.7% | $8.6M+120.6% | $585K-89.9% |
| Financing Cash Flow | $2.8M+747.6% | $1.4M | N/A | N/A | -$435K | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
PLUR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 58.5%+6.5pp | 33.5%+1.7pp | 43.4%-16.6pp | 36.4%-25.0pp | 52.0%-43.8pp | 31.9%-68.2pp | 60.0%-40.0pp | 61.4%-38.6pp |
| Operating Margin | -1655.5% | -3913.8% | -3285.9% | -2009.5% | -1663.6% | -1264.6% | -2679.5% | -1594.5% |
| Net Margin | -1755.2% | -3322.2% | -3304.5% | -1851.3% | 9606.8% | -1439.6% | -1597.8% | -1804.3% |
| Return on Assets | -23.6%-4.0pp | -21.3%-4.9pp | -21.4%-11.8pp | -17.4%-0.8pp | -19.6%-112.0pp | -16.4%-1.9pp | -9.6%+2.2pp | -16.6%-5.5pp |
| Current Ratio | 0.27-0.4x | 0.33-4.5x | 0.43-4.6x | 0.53-5.4x | 0.68-6.3x | 4.81-1.2x | 5.04-2.1x | 5.90-2.3x |
| Asset Turnover | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x |
| FCF Margin | -1334.0% | -2728.1% | -2854.6% | -1754.4% | -1491.7% | -1142.9% | -2562.2% | -1310.4% |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$23.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.27), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Pluri Inc. PLUR | FY2026 | $1.0M | -$23.8M | N/A | $12.0M | 41/100 |
| LAVA Therapeutics N.V. LVTX | FY2024 | $12.0M | -$25.1M | N/A | $45.8M | 53/100 |
| Estrella Immunopharma, Inc. ESLA | FY2025 | N/A | -$13.1M | N/A | $17.8M | — |
| Century Therapeutics, Inc. IPSC | FY2025 | $109.2M | -$9.6M | -8.8% | $266.2M | 59/100 |
| PepGen Inc. PEPG | FY2025 | N/A | -$89.7M | N/A | $181.5M | — |
| Lantern Pharma Inc. LTRN | FY2025 | N/A | -$17.1M | N/A | $12.1M | — |
Where Pluri Inc. Ranks
Frequently Asked Questions
What is Pluri Inc.'s annual revenue?
Pluri Inc. (PLUR) reported $1.0M in total revenue for fiscal year 2026. This represents a -24.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Pluri Inc.'s revenue growing?
Pluri Inc. (PLUR) revenue declined by 24.0% year-over-year, from $1.3M to $1.0M in fiscal year 2026.
Is Pluri Inc. profitable?
No, Pluri Inc. (PLUR) reported a net income of -$23.8M in fiscal year 2026.
What is Pluri Inc.'s EBITDA?
Pluri Inc. (PLUR) had EBITDA of -$24.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Pluri Inc.'s gross margin?
Pluri Inc. (PLUR) had a gross margin of 44.6% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Pluri Inc.'s free cash flow?
Pluri Inc. (PLUR) recorded an outflow of $20.2M in free cash flow during fiscal year 2026. This represents a -2.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Pluri Inc.'s operating cash flow?
Pluri Inc. (PLUR) recorded an outflow of $19.6M in operating cash flow during fiscal year 2026, representing cash used by core business activities.
What are Pluri Inc.'s total assets?
Pluri Inc. (PLUR) had $24.9M in total assets as of fiscal year 2026, including both current and long-term assets.
What are Pluri Inc.'s capital expenditures?
Pluri Inc. (PLUR) invested $633K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Pluri Inc. spend on research and development?
Pluri Inc. (PLUR) invested $15.1M in research and development during fiscal year 2026.
What is Pluri Inc.'s current ratio?
Pluri Inc. (PLUR) had a current ratio of 0.27 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.
What is Pluri Inc.'s return on assets (ROA)?
Pluri Inc. (PLUR) had a return on assets of -95.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Pluri Inc.'s P/E ratio?
Pluri Inc. (PLUR) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2026). The market capitalization is $12.0M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Pluri Inc.'s price-to-sales ratio?
Pluri Inc. (PLUR) trades at 11.8x sales, its market capitalization divided by revenue of $1.0M revenue, FY2026. The market capitalization is $12.0M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Pluri Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2026, Pluri Inc. (PLUR) held $3.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $19.6M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is Pluri Inc.'s debt-to-equity ratio negative or not reported?
Pluri Inc. (PLUR) has negative shareholder equity of -$23.0M as of fiscal year 2026, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Pluri Inc.'s Altman Z-Score?
Pluri Inc. (PLUR) has an Altman Z-Score of -30.55, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Pluri Inc.'s Piotroski F-Score?
Pluri Inc. (PLUR) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Pluri Inc.'s earnings high quality?
Pluri Inc. (PLUR) reported a net loss of $23.8M while operations used $19.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Pluri Inc. cover its interest payments?
Pluri Inc. (PLUR) reported an operating loss of $24.9M against $932K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Pluri Inc.?
Pluri Inc. (PLUR) scores 41 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.